Evaluating Pharmacy Student Performance on Acute Care Advanced Pharmacy Practice Experiences (APPEs)

2007 ◽  
Vol 14 (2) ◽  
pp. 91-104
Author(s):  
Freddy M. Creekmore
Author(s):  
Sujita W Narayan ◽  
Ivo Abraham ◽  
Brian L Erstad ◽  
Curtis E Haas ◽  
Arthur Sanders ◽  
...  

Abstract Purpose Cost-avoidance studies are common in pharmacy practice literature. This scoping review summarizes, critiques, and identifies current limitations of the methods that have been used to determine cost avoidance associated with pharmacists’ interventions in acute care settings. Methods An Embase and MEDLINE search was conducted to identify studies that estimated cost avoidance from pharmacist interventions in acute care settings. We included studies with human participants and articles published in English from July 2010 to January 2021, with the intent of summarizing the evidence most relevant to contemporary practice. Results The database search retrieved 129 articles, of which 39 were included. Among these publications, less than half (18 of 39) mentioned whether the researchers assigned a probability for the occurrence of a harmful consequence in the absence of an intervention; thus, a 100% probability of a harmful consequence was assumed. Eleven of the 39 articles identified the specific harm that would occur in the absence of intervention. No clear methods of estimating cost avoidance could be identified for 7 studies. Among all 39 included articles, only 1 attributed both a probability to the potential harm and identified the cost specific to that harm. Conclusion Cost-avoidance studies of pharmacists’ interventions in acute care settings over the last decade have common flaws and provide estimates that are likely to be inflated. There is a need for guidance on consistent methodology for such investigations for reporting of results and to confirm the validity of their economic implications.


2018 ◽  
Vol 53 (5) ◽  
pp. 471-477 ◽  
Author(s):  
Mary-Haston Leary ◽  
Kathryn Morbitzer ◽  
Bobbi Jo Walston ◽  
Stephen Clark ◽  
Jenna Kaplan ◽  
...  

Background: Despite widespread recognition of the need for innovative pharmacy practice approaches, the development and implementation of value-based outcomes remains difficult to achieve. Furthermore, gaps in the literature persist because the majority of available literature is retrospective in nature and describes only the clinical impact of pharmacists’ interventions. Objective: Length of stay (LOS) is a clinical outcome metric used to represent efficiency in health care. The objective of this study was to evaluate the impact of pharmacist-driven interventions on LOS in the acute care setting. Methods: A separate samples pretest-posttest design was utilized to compare the effect of pharmacist interventions across 3 practice areas (medicine, hematology/oncology, and pediatrics). Two time periods were evaluated: preimplementation (PRE) and a pilot period, postimplementation of interventions (POST). Interventions included targeted discharge services, such as discharge prescription writing (with provider cosignature). Participating pharmacists completed semistructured interviews following the pilot. Results: A total of 924 patients (466 PRE and 458 POST) were included in the analysis. The median LOS decreased from 4.95 (interquartile range = 3.24-8.5) to 4.12 (2.21-7.96) days from the PRE versus POST groups, respectively ( P < 0.011). There was no difference in readmission rates between groups (21% vs 19.1%, P = 0.7). Interviews revealed several themes, including positive impact on professional development. Conclusion and Relevance: This pilot study demonstrated the ability of pharmacist interventions to reduce LOS. Pharmacists identified time as the primary barrier and acknowledged the importance of leaders prioritizing pharmacists’ responsibilities. This study is novel in targeting LOS, providing a value-based outcome for clinical pharmacy services.


2019 ◽  
Vol 217 (2) ◽  
pp. 323-328 ◽  
Author(s):  
Jackie S. Cha ◽  
Nicholas E. Anton ◽  
Tomoko Mizota ◽  
Julie M. Hennings ◽  
Megan A. Rendina ◽  
...  

2000 ◽  
Vol 57 (19) ◽  
pp. 1759-1775 ◽  
Author(s):  
Debra Jones Ringold ◽  
John P. Santell ◽  
Philip J. Schneider

2019 ◽  
Vol 83 (9) ◽  
pp. 7331
Author(s):  
Laura Baumgartner ◽  
Eric J. Ip ◽  
Debbie Sasaki-Hill ◽  
Terri Wong ◽  
Heidi Israel ◽  
...  

2005 ◽  
Vol 69 (3) ◽  
pp. 51 ◽  
Author(s):  
Nathan R. Kuncel ◽  
Marcus Credé ◽  
Lisa L. Thomas ◽  
David M. Klieger ◽  
Stephanie N. Seiler ◽  
...  

Author(s):  
Catherine A. Forrester ◽  
Da Sol Lee ◽  
Ethel Hon ◽  
Kai Ying Lim ◽  
Tina P. Brock ◽  
...  

Author(s):  
Michael W. Perry ◽  
Lawrence R. Kobulinsky ◽  
Amy L. Seybert ◽  
Madeline S. Kreider ◽  
Victoria Williams ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document